caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · Loading…
caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1306018221

NPI 1306018221

PRACTICEENDOCRINE ASSOCIATES LLCSee all providers at this practice →
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (2)

CCN 070010
Hospital
CCN 070028
Hospital
REFERRAL NETWORK

Where NPI 1306018221's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 4 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Quest Diagnostics Llc
Clinical Laboratory · Wallingford, CT
65242
American Medical Response Of Connecticut Incorporated
Ambulance Service Provider · New Haven, CT
1122
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$76
Payment records
5
By payment type
Food and Beverage$76
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
276
Unique beneficiaries
—
Total services
356
Distinct HCPCS
7
Medicare payment
$27K
PRESCRIBING · PART D · 2024
Total Rx claims
1,996
Beneficiaries
—
Total drug cost
$719K
Distinct drugs
38
Brand share
49.9%
Top prescribed drugs
Levothyroxine Sodium503 claims
Semaglutide164 claims
Metformin Hcl133 claims
Levothyroxine Sodium133 claims
Alendronate Sodium85 claims
QUALITY · MIPS · 2024
Final MIPS score
90.4
Quality
83.4
Cost
75.9
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.65%
Group